Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Tevas UK arm recalls some batches of Ranitidine: Medicines watchdog

      Teva's UK arm recalls some batches of Ranitidine: Medicines watchdog

      Medical Dialogues Bureau18 Oct 2019 9:14 AM IST
      Teva Pharmaceutical’s UK unit has recalled some batches of heartburn medicine Ranitidine, Britain’s medicines watchdog said on Thursday, making it the...
      USFDA red flags Glenmark over batch failure investigations at Baddi facility

      USFDA red flags Glenmark over batch failure investigations at Baddi facility

      Medical Dialogues Bureau17 Oct 2019 1:28 PM IST
      New Delhi: The US health regulator has red flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and...
      Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

      Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

      Medical Dialogues Bureau17 Oct 2019 1:14 PM IST
      New Delhi: Sun Pharmaceutical Industries recently announced that one of its wholly-owned subsidiaries has launched Drizalma Sprinkle™ (duloxetine...
      Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

      Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

      Medical Dialogues Bureau17 Oct 2019 12:19 PM IST
      "This is the first time in India when such large number of pharmacists have been penalised. We have also issued warnings to around 3,000 pharmacists...
      Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

      Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

      Medical Dialogues Bureau17 Oct 2019 9:28 AM IST
      New Delhi: Max Healthcare super speciality hospital in the National Capital on Tuesday signed a partnership with Japan's Fujifilm to train doctors in...
      Mylan moves application with DCGI to launch new TB drug Pretomanid in India

      Mylan moves application with DCGI to launch new TB drug Pretomanid in India

      Medical Dialogues Bureau16 Oct 2019 4:10 PM IST
      "We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
      JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

      JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

      Medical Dialogues Bureau16 Oct 2019 10:00 AM IST
      JnJ is facing more than 13,000 lawsuits tied to anti-psychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids,...
      Granules India to exit from Chinese JV Granules Biocause

      Granules India to exit from Chinese JV Granules Biocause

      Medical Dialogues Bureau15 Oct 2019 3:07 PM IST
      Granules India formed the Chinese joint venture, Granules Biocause Pharmaceuticals in 2007 to ensure a regular supply of ibuprofen API to support its...
      Allergan shareholders okays USD 63 billion AbbVie acquisition

      Allergan shareholders okays USD 63 billion AbbVie acquisition

      Medical Dialogues Bureau15 Oct 2019 9:30 AM IST
      Under the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
      Roche Rituximab shows positive data in rare skin disease Pemphigus Vulgaris

      Roche Rituximab shows positive data in rare skin disease Pemphigus Vulgaris

      Medical Dialogues Bureau15 Oct 2019 9:00 AM IST
      New Delhi: Roche recently announced data from the Phase III PEMPHIX study evaluating the efficacy and safety of MabThera/Rituxan (rituximab) compared...
      Torrent Pharma recalls bottles of Losartan over CGMP deviations

      Torrent Pharma recalls bottles of Losartan over CGMP deviations

      Medical Dialogues Bureau14 Oct 2019 9:30 AM IST
      As per USFDA report, Torrent Pharma is also recalling 39,432 bottles of Losartan Potassium Tablets, USP in the strength of 100 mg from the US and...
      Novartis gets USFDA nod for Beovu for wet Age-related Macular Degeneration

      Novartis gets USFDA nod for Beovu for wet Age-related Macular Degeneration

      Medical Dialogues Bureau13 Oct 2019 9:30 AM IST
      New Delhi: Novartis recently announced that the U.S. Food and Drug Administration (FDA) approved Beovu (brolucizumab) injection, also known as RTH258...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok